
May 15, 2020
Counted: The Top 10 Superheroes That Wear Masks
No mention of ZORRO or THE LONE RANGER!WE NEED SOME NEW HEROS WHO WEAR THEIR MASKS WHEN THE ARE AROUND OTHER PEOPLE.
Note Current Data for Harrison County compiled and grafted by Edmund Wood.
Texas reports 58 coronavirus deaths in one day, a record (from the Houston Chronicle)
Gregg County COVID-19 cases jump by 29; official says most in one nursing home (from Longview paper)
From the Shreveport paper: Caddo Parish increased from 1,800 cases on Wednesday to 1,818 on Thursday, according to data from the Louisiana Department of Health.
The number of COVID-19 related deaths reached 161, the Caddo Parish Coroner’s office reported.
The first Caddo Parish coronavirus death occurred March 24.
Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19 (ARE NOT AN ADDITIONAL RISK FACTOR IN COVID -19 INFECTIONS–ARE AS SAFE AS OTHER BLOOD PRESSURE PILLS)
“…Compared with the use of other antihypertensive drugs, current use of RAAS inhibitors was not associated with increased risk of COVID-19 requiring admission to hospital (odds ratio [OR] 0·94, 95% CI 0·77–1·15, adjusted for potential confounding factors), or increased risk of severe complications from COVID-19 needing intensive care or leading to a fatal outcome (1·08, 0·80–1·47). These findings were uninfluenced by age, sex, or background cardiovascular risk. Moreover, excluding aldosterone antagonists and renin inhibitors and focusing only on ACE inhibitors or angiotensin-receptor blockers made no difference to these conclusions.”J. Harris Comment: This is to say that a common class of blood pressure pills is just as safe as any other. Hypertension itself is a risk factor, or course.
ACE INHIBITORS:benazepril (Lotensin, Lotensin Hct),captopril (Capoten),
enalapril (Vasotec),
fosinopril (Monopril),
lisinopril (Prinivil, Zestril),
moexipril (Univasc)
perindopril (Aceon),
quinapril (Accupril),
ramipril (Altace), and
trandolapril (Mavik).
ACE BLOCKERS (about the same thing as inhibitors):Azilsartan (Edarbi)
- Candesartan (Atacand)
- Eprosartan.
- Irbesartan (Avapro)
- Losartan (Cozaar)
- Olmesartan (Benicar)
- Telmisartan (Micardis)
- Valsartan (Diovan)
Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study
Conclusion
In hospitalized pregnant women with severe or critical COVID-19 infection, admission typically occurred about 7 days after symptom onset, and the duration of hospitalization was 6 days (6 severe versus 12 critical). Critically ill women had a high rate of ARDS, and there was one case of cardiac arrest, but there were no cases of cardiomyopathy, or maternal mortality. Hospitalization for severe or critical COVID-19 infection resulted in delivery during the course of infection in 50% of this cohort, usually in the third trimester. There were no perinatal deaths in this cohort.
(HOW ABOUT SOME GOOD NEWS: ALL THE MOTHERS AND BABIES LIVED).
(This is a cohort study of pregnant women with severe or critical COVID-19 infection hospitalized at 12 US institutions between March 5, 2020 and April 20, 2020.
Of 64 pregnant women hospitalized with COVID-19, 44 (69%) had severe and 20 (31%) critical disease).
FROM JOHNS HOPKINS:
Abbott Coronavirus Test Missed a Large Number of Positive Results Caught by a Rival Firm, Preliminary Study Says (Washington Post) The Abbott coronavirus test hailed by President Trump and used by the White House failed to detect infected samples in a large number of cases that were caught by a rival firm, a preliminary study says. The speedy Abbott test, which is supposed to determine in five to 13 minutes whether a person has the virus, missed a third of the positive samples found by the diagnostic company Cepheid when both tests used nasopharyngeal swabs, said the study done by a group from New York University. It missed more than 48 percent when both firms’ tests used dry nasal swabs.
ANOTHER FABULOUS STATICAL COMPILATION AND GRAFT BY EDMUND WOOD OF MARSHALL: Note our proximity to LA problem areas.
GIVE US YOUR FEEDBACK. CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.
